SEC Form 4
Elevance Health, Inc. (ELV) insider trading
In the 12 months to Oct 24, 2026, 4 ELV insiders reported open-market sales of $1.7M across 5 filings; 3 insiders bought $2.2M.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $1.7M
- 5 filings · 4 insiders
- Open-market purchases
- $2.2M
- 3 filings
Who traded ELV, and when
- Purchase
- Sale
ELV daily close from Oct 24, 2025 to Oct 23, 2026, between $280.74 and $445.28, last $439.95. 5 sale and 3 purchase filings by 7 insiders, marked at their filing dates. Gail Boudreaux, President and CEO: bought $1.0M across 1 filing, first filed Jul 17, 2026, last Jul 17, 2026. Charles Morgan Kendrick JR., EVP & President, Commercial: sold $910.6K across 1 filing, first filed Mar 9, 2026, last Mar 9, 2026. Steven H. Collis, Director: bought $869.5K across 1 filing, first filed Mar 6, 2026, last Mar 6, 2026. Ronald W. Penczek, CAO & Controller: sold $766.0K across 2 filings, first filed May 20, 2026, last Jun 15, 2026. Ramiro G. Peru, Director: bought $366.1K across 1 filing, first filed Jul 17, 2026, last Jul 17, 2026. Robert L. Dixon JR., Director: sold $60.7K across 1 filing, first filed Jun 12, 2026, last Jun 12, 2026. Amy W. Schulman, Director: sold $7.5K across 1 filing, first filed Mar 23, 2026, last Mar 23, 2026.
Largest mark · tap a row for others
Gail Boudreaux · President and CEO
Purchase $1,002,230
2,725 shares at $367.79 avg
Filed Jul 17, 2026
Close on filing date $373.11
Gail Boudreaux · President and CEO
President and CEO
$1.0M boughtCharles Morgan Kendrick JR. · EVP & President, Commercial
EVP & President, Commercial
$910.6K soldSteven H. Collis · Director
Director
$869.5K boughtRonald W. Penczek · CAO & Controller
CAO & Controller
$766.0K soldRamiro G. Peru · Director
Director
$366.1K boughtRobert L. Dixon JR. · Director
Director
$60.7K soldAmy W. Schulman · Director
Director
$7.5K soldHas Elevance Health, Inc.'s CEO sold stock?
No. Gail Boudreaux (CEO) made no open-market sales filed as CEO in the last 12 months.
Open-market trades
8 filings in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| Gail Boudreaux | President and CEO | — | $1.0M | 1 | — | |
| Charles Morgan Kendrick JR. | EVP & President, Commercial | $910.6K | — | 1 | — | |
| Steven H. Collis | Director | — | $869.5K | 1 | — | |
| Ronald W. Penczek | CAO & Controller | $766.0K | — | 2 | — | |
| Ramiro G. Peru | Director | — | $366.1K | 1 | — | |
| Robert L. Dixon JR. | Director | $60.7K | — | 1 | — | |
| Amy W. Schulman | Director | $7.5K | — | 1 | — |
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
traded | Ramiro G. Peru Director | Purchase | 1,000 | $366.05 | $366.1K | 10,908 | |
traded | Gail Boudreaux President and CEO | Purchase | 2,725 | $367.79 | $1.0M | 169,931 | |
traded | Ronald W. Penczek CAO & Controller | Sale | 369 | $403.16 | $148.8K | 3,740 | |
traded | Robert L. Dixon JR. Director | Sale | 151 | $401.77 | $60.7K | 10,734 | |
traded | Ronald W. Penczek CAO & Controller | Sale | 1,531 | $403.13 | $617.2K | 4,109 | |
traded | Amy W. Schulman Director | Sale | 26 | $287.50 | $7.5K | 218 | |
traded | Charles Morgan Kendrick JR. EVP & President, Commercial | Sale | 3,196 | $284.92 | $910.6K | 11,791 | |
traded | Steven H. Collis Director | Purchase | 3,000 | $289.84 | $869.5K | 3,639 |
GET /stocks/filings/vX/form-4?tickers=ELV&filing_date.gte=2025-10-24&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"ELV"
],
"issuer_cik": "0001156039",
"owner_cik": "0001287920",
"accession_number": "0001287920-26-000006",
"form_type": "4",
"filing_date": "2026-07-17",
"period_of_report": "2026-07-17",
"issuer_name": "Elevance Health, Inc.",
"issuer_trading_symbol": "ELV",
"owner_name": "BOUDREAUX GAIL",
"is_director": true,
"is_officer": true,
"is_ten_percent_owner": false,
"is_other": false,
"officer_title": "President and CEO",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-07-17",
"transaction_code": "P",
"equity_swap_involved": false,
"transaction_shares": 2045,
"transaction_price_per_share": 368.25,
"transaction_acquired_disposed": "A",
"shares_owned_following_transaction": 171976,
"transaction_value": 753071.25,
"not_subject_to_section_16": false,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F2",
"description": "This transaction was executed in multiple purchases at prices ranging from $367.76 to $368.69. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."
}
]
},
{
"tickers": [
"ELV"
],
"issuer_cik": "0001156039",
"owner_cik": "0001192045",
"accession_number": "0001192045-26-000004",
"form_type": "4",
"filing_date": "2026-07-17",
"period_of_report": "2026-07-17",
"issuer_name": "Elevance Health, Inc.",
"issuer_trading_symbol": "ELV",
"owner_name": "PERU RAMIRO G",
"is_director": true,
"is_officer": false,
"is_ten_percent_owner": false,
"is_other": false,
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-07-17",
"transaction_code": "P",
"equity_swap_involved": false,
"transaction_shares": 1000,
"transaction_price_per_share": 366.05,
"transaction_acquired_disposed": "A",
"shares_owned_following_transaction": 10908,
"transaction_value": 366050,
"not_subject_to_section_16": false,
"direct_or_indirect": "D"
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 52 records
- Option exercises2 records
- Tax withholding22 records
- Grants and awards28 records
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
Build this yourself
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for ELV every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.